|
Market Closed -
London S.E.
11:35:16 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 65.00 GBX | +1.56% |
|
-2.99% | -38.68% |
| 08-07 | EARNINGS AND TRADING: Probiotix flips to profit, eyes "further growth" | AN |
| 08-06 | Ingenta Buys Minority Stake in AI-based Legal Software Company FirstAida | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.33 | 8.5 | 14.33 | 12.14 | 11.66 | |||||
Return on Total Capital | 9.81 | 16.68 | 25.8 | 18.9 | 16.6 | |||||
Return On Equity % | 43.45 | 34.34 | 47.23 | 21.16 | 25.55 | |||||
Return on Common Equity | 43.45 | 34.34 | 47.23 | 21.16 | 25.55 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 45.91 | 48.83 | 49.85 | 48.88 | 51.98 | |||||
SG&A Margin | 38.48 | 37.15 | 30.92 | 30.96 | 34.36 | |||||
EBITDA Margin % | 9.2 | 13.11 | 19.8 | 18.46 | 18.28 | |||||
EBITA Margin % | 7.43 | 11.67 | 18.93 | 17.91 | 17.61 | |||||
EBIT Margin % | 7.43 | 11.67 | 18.93 | 17.91 | 17.61 | |||||
Income From Continuing Operations Margin % | 17.75 | 13.96 | 21.24 | 12.54 | 16.94 | |||||
Net Income Margin % | 17.75 | 13.96 | 21.24 | 12.54 | 16.94 | |||||
Net Avail. For Common Margin % | 17.75 | 13.96 | 21.24 | 12.54 | 16.94 | |||||
Normalized Net Income Margin | 4.48 | 7.17 | 11.73 | 11.18 | 11.31 | |||||
Levered Free Cash Flow Margin | 14.94 | 15.62 | 4.36 | 8.19 | 13.74 | |||||
Unlevered Free Cash Flow Margin | 15.1 | 15.74 | 4.46 | 8.21 | 13.75 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.15 | 1.17 | 1.21 | 1.08 | 1.06 | |||||
Fixed Assets Turnover | 11.37 | 21.62 | 54.81 | 95.32 | 100.2 | |||||
Receivables Turnover (Average Receivables) | 6.48 | 6.88 | 6.37 | 5.89 | 8.05 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.12 | 0.89 | 1.36 | 1.81 | 2.28 | |||||
Quick Ratio | 1.06 | 0.82 | 1.26 | 1.67 | 2.14 | |||||
Operating Cash Flow to Current Liabilities | 0.47 | 0.51 | 0.32 | 0.53 | 0.63 | |||||
Days Sales Outstanding (Average Receivables) | 56.34 | 53.03 | 57.32 | 62.12 | 45.37 | |||||
Average Days Payable Outstanding | 24.08 | 21.87 | 24.27 | 28.04 | 27.2 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 9.53 | 5.09 | - | - | - | |||||
Total Debt / Total Capital | 8.7 | 4.84 | - | - | - | |||||
LT Debt/Equity | 4.06 | - | - | - | - | |||||
Long-Term Debt / Total Capital | 3.71 | - | - | - | - | |||||
Total Liabilities / Total Assets | 49.23 | 56.28 | 38.71 | 32.89 | 26.8 | |||||
EBIT / Interest Expense | 27.93 | 58.1 | 120.53 | 913.5 | 603 | |||||
EBITDA / Interest Expense | 49.19 | 77.71 | 137.47 | 941.5 | 625.67 | |||||
(EBITDA - Capex) / Interest Expense | 44.78 | 75.57 | 132.76 | 899.5 | 615.33 | |||||
Total Debt / EBITDA | 0.34 | 0.12 | - | - | - | |||||
Net Debt / EBITDA | -1.92 | -1.34 | -1.15 | -1.92 | -2.5 | |||||
Total Debt / (EBITDA - Capex) | 0.37 | 0.12 | - | - | - | |||||
Net Debt / (EBITDA - Capex) | -2.11 | -1.38 | -1.19 | -2.01 | -2.54 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -0.31 | 3.02 | 3.58 | -5.78 | 0.7 | |||||
Gross Profit, 1 Yr. Growth % | 5 | 9.55 | -0.13 | -7.62 | 7.08 | |||||
EBITDA, 1 Yr. Growth % | -8.62 | 28.52 | 28.32 | -12.13 | -0.32 | |||||
EBITA, 1 Yr. Growth % | -17.23 | 61.8 | 34.8 | -10.83 | -0.99 | |||||
EBIT, 1 Yr. Growth % | -17.23 | 61.8 | 34.8 | -10.83 | -0.99 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 301.11 | -18.99 | 30.7 | -44.37 | 36.04 | |||||
Net Income, 1 Yr. Growth % | 301.11 | -18.99 | 30.7 | -44.37 | 36.04 | |||||
Normalized Net Income, 1 Yr. Growth % | -18.22 | 64.92 | 35.56 | -10.19 | 1.86 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 310.16 | -14.86 | 43.78 | -44.52 | 39.42 | |||||
Accounts Receivable, 1 Yr. Growth % | -14.78 | 6.6 | 16.98 | -11.13 | -43.28 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -40.57 | -54.59 | -69.21 | 30.11 | -30.58 | |||||
Total Assets, 1 Yr. Growth % | 10.95 | -7.22 | 7 | 3.65 | 2.64 | |||||
Tangible Book Value, 1 Yr. Growth % | 143.57 | -46.05 | 112.31 | 25.47 | 20.4 | |||||
Common Equity, 1 Yr. Growth % | 32.47 | -20.11 | 38.95 | 13.5 | 11.95 | |||||
Cash From Operations, 1 Yr. Growth % | 153.22 | 21.97 | -53.62 | 45.98 | 0.24 | |||||
Capital Expenditures, 1 Yr. Growth % | -40.5 | -62.18 | 77.78 | 5 | -63.1 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 142.22 | 7.72 | -68.94 | 77.04 | 68.83 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 139.65 | 7.39 | -68.52 | 73.4 | 68.8 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 15 | 18.84 | 0 | 9.76 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -3.61 | 1.34 | 3.3 | -1.21 | -2.6 | |||||
Gross Profit, 2 Yr. CAGR % | -0.83 | 7.25 | 7.63 | -3.95 | -0.54 | |||||
EBITDA, 2 Yr. CAGR % | 35.66 | 15.84 | 41.79 | 6.19 | -6.41 | |||||
EBITA, 2 Yr. CAGR % | 34.79 | 15.72 | 64.85 | 9.63 | -6.04 | |||||
EBIT, 2 Yr. CAGR % | 34.79 | 15.72 | 64.85 | 9.63 | -6.04 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 15.54 | 80.26 | 12.98 | -14.73 | -13 | |||||
Net Income, 2 Yr. CAGR % | 15.54 | 80.26 | 12.98 | -14.73 | -13 | |||||
Normalized Net Income, 2 Yr. CAGR % | 35.32 | 16.13 | 67.18 | 10.34 | -4.35 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 14.71 | 86.87 | 21.5 | -10.68 | -12.05 | |||||
Accounts Receivable, 2 Yr. CAGR % | -18.72 | -3.74 | 11.67 | 1.96 | -29 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 18.57 | -48.05 | -62.6 | -36.7 | -4.96 | |||||
Total Assets, 2 Yr. CAGR % | 1.06 | 1.46 | -0.37 | 5.31 | 3.14 | |||||
Tangible Book Value, 2 Yr. CAGR % | 70.22 | 14.63 | 20.59 | 63.21 | 22.91 | |||||
Common Equity, 2 Yr. CAGR % | 15.67 | 2.88 | 9.47 | 25.58 | 12.72 | |||||
Cash From Operations, 2 Yr. CAGR % | 1.95 | 75.74 | -24.79 | -17.72 | 20.97 | |||||
Capital Expenditures, 2 Yr. CAGR % | -5.05 | -52.57 | -18.01 | 36.63 | -37.75 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -6.63 | 61.53 | -44.19 | -25.85 | 72.88 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -6.41 | 60.42 | -43.88 | -26.11 | 71.08 | |||||
Dividend Per Share, 2 Yr. CAGR % | 41.42 | 7.24 | 16.9 | 9.01 | 4.76 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -5.45 | -1.45 | 2.08 | 0.18 | -0.58 | |||||
Gross Profit, 3 Yr. CAGR % | -0.6 | 2.52 | 6.75 | 2.29 | -0.4 | |||||
EBITDA, 3 Yr. CAGR % | 83.1 | 39.28 | 28.04 | 20.88 | 3.97 | |||||
EBITA, 3 Yr. CAGR % | 39.29 | 43.25 | 31.02 | 34.31 | 5.97 | |||||
EBIT, 3 Yr. CAGR % | 39.29 | 43.25 | 31.02 | 34.31 | 5.97 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 31.23 | 2.65 | 72.36 | -10.78 | -0.36 | |||||
Net Income, 3 Yr. CAGR % | 31.23 | 2.65 | 72.36 | -10.78 | -0.36 | |||||
Normalized Net Income, 3 Yr. CAGR % | 33.15 | 44.55 | 31.73 | 35.91 | 7.44 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 30.63 | 3.86 | 82.26 | -6.44 | 3.61 | |||||
Accounts Receivable, 3 Yr. CAGR % | -23.93 | -10.44 | 2.72 | 3.48 | -16.14 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 4.48 | -13.89 | -56.36 | -43.33 | -34.72 | |||||
Total Assets, 3 Yr. CAGR % | -6.68 | -1.78 | 3.27 | 0.95 | 4.41 | |||||
Tangible Book Value, 3 Yr. CAGR % | 50.93 | 16.06 | 52.43 | 22.19 | 47.47 | |||||
Common Equity, 3 Yr. CAGR % | -3.04 | 2.24 | 16.66 | 10.8 | 20.86 | |||||
Cash From Operations, 3 Yr. CAGR % | 372.4 | 8.23 | 12.72 | -6.18 | -12.12 | |||||
Capital Expenditures, 3 Yr. CAGR % | 24.95 | -30.14 | -26.32 | -10.96 | -11.68 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 57.96 | -2.07 | -8.96 | -18 | -2.45 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 61.11 | -2.02 | -8.95 | -18.26 | -2.69 | |||||
Dividend Per Share, 3 Yr. CAGR % | 25.99 | 32 | 10.97 | 10.97 | 9.26 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -7.77 | -6.59 | -2.04 | -1.36 | 0.18 | |||||
Gross Profit, 5 Yr. CAGR % | -4.4 | -1.93 | 2.61 | 1.03 | 3.77 | |||||
EBITDA, 5 Yr. CAGR % | -0.21 | 4.87 | 69.76 | 30.01 | 12.95 | |||||
EBITA, 5 Yr. CAGR % | 0.08 | 5.58 | 49 | 34.5 | 14.71 | |||||
EBIT, 5 Yr. CAGR % | 0.08 | 5.58 | 49 | 34.5 | 14.71 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 12.51 | 8.17 | 23.6 | -1.06 | 31.12 | |||||
Net Income, 5 Yr. CAGR % | 12.51 | 8.17 | 23.6 | -1.06 | 31.12 | |||||
Normalized Net Income, 5 Yr. CAGR % | -4.09 | 8.43 | 45.84 | 35.67 | 15.9 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 11.92 | 9.11 | 26.9 | 1.51 | 36.18 | |||||
Accounts Receivable, 5 Yr. CAGR % | -17.06 | -10.95 | -10.95 | -5.67 | -11.39 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 26.78 | 16.62 | -30.73 | -23.86 | -40.42 | |||||
Total Assets, 5 Yr. CAGR % | -7.16 | -7.45 | -4.21 | 1 | 3.22 | |||||
Tangible Book Value, 5 Yr. CAGR % | 111.28 | 1.33 | 37.97 | 39.52 | 39.86 | |||||
Common Equity, 5 Yr. CAGR % | -2.66 | -9.74 | 1.78 | 12.72 | 15.07 | |||||
Cash From Operations, 5 Yr. CAGR % | 93.94 | 38.12 | 126.51 | -3.01 | 15.95 | |||||
Capital Expenditures, 5 Yr. CAGR % | 11.52 | -13.14 | 5.57 | -8.64 | -31.12 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 19.97 | 27.57 | 4.19 | -13.63 | 17.66 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 19.63 | 28.83 | 5.67 | -13.71 | 17.18 | |||||
Dividend Per Share, 5 Yr. CAGR % | 24.57 | 18.13 | 22.28 | 22.28 | 8.45 |
- Stock Market
- Stocks
- ING Stock
- Financials Ingenta plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















